June 1, 2018 NINDS and NCI Director's highlight Dr. Lesniak's research. To read the full story, click here.
June 14, 2017 Congratulations to Dou Yu on the acceptance of his manuscript "Mutliplexed RNAi therapy against brain tumor initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression" in PNAS! (IF=9.4) Co-authors included Drs. Kahn, Suva, Dong, Panek, Zia, Wu, Han, Ahmed, Balyasnikova, Zhang, Sun, Langer, and Anderson. Absolutely great work everyone!
June 3, 2017 Congratulations to Megan and Jason on the publication of their paper "Fatty acid uptake in T cell subsets using a quantum dot fatty acid conjugate" in Scientific Reports (IF=5.2) Co-authors included Alan, Peng, Aida, Haley, Aurora, and Yu.
May, 2017 Our phase I clinical trial was FDA approved an now enrolling patients. Read all about it here.
April 27, 2017 Congratulations to Julius on the publication of his paper "A comparative analysis of replication incompetent and competent adenoviral therapy mediated immune response in a murine glioma model" in Molecular Therapy-Oncolytics. Co-authors included Jason, Aida, Josh, Wojtek, Deepak, and Irina.
April 26, 2017 Congratulations to Dr. Peng Zhang on receiving the ABTA post-doctoral award for $100,000 for two years.
December 21, 2016 Pictures from the holiday party are available for viewing here.
December 6, 2016 Congratulations to Dr. Irina Balyasnikova for being named a regular member of the GDD (Gene and Drug Delivery Study Section). Irina's term will begin in 2017 and last for 6 years.
December 3, 2016 Please join me in congratulating Dr. Dou Yu on securing a new grant from the Elsa U Pardee Foundation entitled "CRISPR engineering of NINJA stem cells for malignant glioma brain tumor therapy".
September 28, 2016 Congratulations to Aida and Jason on the acceptance of their manuscript "Anti-GITR therapy promotes immunity against malignant glioma in a murine model" in Cancer Immunology Immunotherapy (IF=4.85). Co-authors included:Alan, Megan, Yu, and Lingjiao. Great job everyone.
July 28, 2016 Please join me in congratulating Alan on the acceptance of his manuscript "Glioma microenvironment-derived CCL2 is essential for recruitment of regulatory T cells and myeloid-derived suppressor cells" in Cancer Research (IF=9.3). Co-authors included: Jason, Derek, Mahua, Claudia, Dou, Deepak, Kasia, Jian, Peter, Yu, Meijing, Lingjiao, and Craig. Awesome!!!
Next Lab Meeting: Thursdays at 9am. Lurie 4 Conference Room.
Future Meetings & Abstracts
American Association for Cancer Research, March 30-April 3, 2019, Atlanta, GA. Abstract Deadline: TBA
American Association of Neurological Surgeons, April 13-17, 2019, San Diego, CA. Abstract Deadline: TBA
American Association of Immunologists, May 9-13, 2019, San Diego, CA. Abstract Deadline: TBA..
American Society of Gene & Cell Therapy, April 29-May 2, 2019, New Washington, DC. Abstract Deadline: TBA.
International Society for Stem Cell Research, June 26-29, 2019; Los Angeles, CA. Abstract Deadline: TBA.
Congress of Neurological Surgeons, October 6-10, 2019. Houston, TX: Abstract Deadline: Passed.
European Association for Neuro-Oncology, September 18-22, 2019, Lyon, France.. Abstract Deadline: TBA
Society for Neuro-Oncology, November 15-18, 2018, New Orleans, LA. Abstract Deadline: June 4, 2018.